December 22, 2011
Medical Device Daily
The Prometheus v. Mayo case was argued at the U.S. Supreme Court earlier in December, and while many of the justices’ questions seemed to reflect positions they were expected to hold, Chief Justice John Roberts asked questions that have prompted at least one patent attorney to speculate that Roberts might find the technology being litigated ineligible for patent protection, which would have a detrimental impact on the future of patents related to diagnostics and personalized medicine. Finnegan partner Denise DeFranco stated if the Court reversed the Federal Circuit, the outcome “could have major implications,” adding, “if they say this claim is invalid, no matter how narrowly they state that, there are a lot of claims like this one” that would be affected
Press Release
October 6, 2026
Commentary
Federal Circuit Revives Whistleblower Complaint Over VA's AI Claims-Processing Tool
September 25, 2026
Award/Ranking
Finnegan Named an IP Litigation Powerhouse in BTI Litigation Outlook 2027
September 24, 2026
Press Release
Finnegan Secures Precedential Pro Bono Federal Circuit Victory for AI Whistleblower
September 23, 2026
Award/Ranking
Finnegan Receives Top Tier Rankings in World Trademark Review’s Inaugural Copyright 1000 2026
September 23, 2026
Commentary
New Thomas Pink Womenswear Lines Strain ‘Pink’ Pact with Victoria’s Secret
September 21, 2026
Commentary
Pepsi's U.S. Trademark Dispute Could Reshape Brand Choices, Lawsuit Strategy, Lawyers Say
September 17, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.